Rashmi Kumari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Rashmi Kumari has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- Biswanath Behera
Department of Dermatology and Venereology, All India Institute of Medical Sciences, Bhubaneshwar, Odisha, India
18 shared publications Debasis Gochhait
Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
14 shared publicationsDevinder Mohan Thappa
Department of Dermatology and STD, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
14 shared publicationsBiswanath Behera
Department of Dermatology, AIIMS, Bhubaneswar, Odisha, India
11 shared publicationsPavithra Ayyanar
AIIMS, Dept Pathol, Bhubaneswar, India
11 shared publications- Debasis Gochhait
Department of Pathology Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) Puducherry India
8 shared publications
Latest Publications
- 17 November 2026
- Published by Wiley in International Journal of Dermatology
A Giant Sacrococcygeal Eumycetoma With Bilateral Gluteal Extension
- 17 November 2026
- Published by Wiley in International Journal of Dermatology
A Giant Sacrococcygeal Eumycetoma With Bilateral Gluteal Extension
- 13 February 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (8) , 1385-1393
Efficacy and safety of surgical excision vs. 70% trichloroacetic acid topical application in xanthelasma palpebrarum: a split-face randomized clinical trial
Background: Despite its frequency, there is a lack of comparative evidence evaluating available treatment modalities for xanthelasma palpebrarum (XP). Although surgical excision and trichloroacetic acid (TCA) are commonly used interventions for XP, no study has compared these two modalities. Objectives: To compare the efficacy and safety of surgical excision vs. 70% TCA in the management of limited XP. Methods: A prospective, split-face, single-blinded, single-centre randomized clinical trial conducted from November 2024 to August 2025 with a 12-week follow-up. Adults aged ≥ 18 years with bilateral XP limited to ≤ one-third of the palpebral area were included. Key exclusion criteria were lesions larger than one-third of the eyelid height or area and lesions within 2 mm of the canthi. These criteria ensured safe and comparable use of both treatments. Each participant contributed two XP units (XPUs, defined as all XP lesions in one eye). One eye XPU in each patient was randomized to surgical excision and the contralateral eye XPU to TCA application (up to three sessions, 4 weeks apart). The primary outcome was complete clearance (100% reduction in XPU surface area) at week 12. Secondary outcomes included cosmetic outcome, patient satisfaction, percentage reduction in size and adverse effects. The trial is registered with the Clinical Trials Registry of India, no. CTRI/2024/10/074929. Results: All excision-treated XPUs (36/36; 100%) achieved complete clearance compared with 8/36 XPUs (22%) treated with TCA (McNemar test; P < 0.001). The median percentage reduction was 100% for excision and 69.2% for TCA (P < 0.001, Wilcoxon signed-rank test). Excellent cosmetic outcomes occurred in 21/36 (58%) excised XPUs vs. 1/8 (13%) TCA-treated XPUs that achieved complete remission. Dyschromia was more common after TCA (27/36, 75%) than excision (15/36, 42%). Older age independently predicted excellent cosmetic outcomes after surgical excision with receiver operating characteristic analysis identifying 51 years as the optimal cutoff. Papulonodular morphology was associated with TCA treatment failure. Conclusions: Surgical excision was more effective than 70% TCA for limited XP, providing predictable single-session clearance, superior cosmetic outcomes, fewer pigmentary changes and higher patient satisfaction. Excision can be considered the preferred first-line therapy for localized XP.
- 13 February 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (8) , 1385-1393
Efficacy and safety of surgical excision vs. 70% trichloroacetic acid topical application in xanthelasma palpebrarum: a split-face randomized clinical trial
Background: Despite its frequency, there is a lack of comparative evidence evaluating available treatment modalities for xanthelasma palpebrarum (XP). Although surgical excision and trichloroacetic acid (TCA) are commonly used interventions for XP, no study has compared these two modalities. Objectives: To compare the efficacy and safety of surgical excision vs. 70% TCA in the management of limited XP. Methods: A prospective, split-face, single-blinded, single-centre randomized clinical trial conducted from November 2024 to August 2025 with a 12-week follow-up. Adults aged ≥ 18 years with bilateral XP limited to ≤ one-third of the palpebral area were included. Key exclusion criteria were lesions larger than one-third of the eyelid height or area and lesions within 2 mm of the canthi. These criteria ensured safe and comparable use of both treatments. Each participant contributed two XP units (XPUs, defined as all XP lesions in one eye). One eye XPU in each patient was randomized to surgical excision and the contralateral eye XPU to TCA application (up to three sessions, 4 weeks apart). The primary outcome was complete clearance (100% reduction in XPU surface area) at week 12. Secondary outcomes included cosmetic outcome, patient satisfaction, percentage reduction in size and adverse effects. The trial is registered with the Clinical Trials Registry of India, no. CTRI/2024/10/074929. Results: All excision-treated XPUs (36/36; 100%) achieved complete clearance compared with 8/36 XPUs (22%) treated with TCA (McNemar test; P < 0.001). The median percentage reduction was 100% for excision and 69.2% for TCA (P < 0.001, Wilcoxon signed-rank test). Excellent cosmetic outcomes occurred in 21/36 (58%) excised XPUs vs. 1/8 (13%) TCA-treated XPUs that achieved complete remission. Dyschromia was more common after TCA (27/36, 75%) than excision (15/36, 42%). Older age independently predicted excellent cosmetic outcomes after surgical excision with receiver operating characteristic analysis identifying 51 years as the optimal cutoff. Papulonodular morphology was associated with TCA treatment failure. Conclusions: Surgical excision was more effective than 70% TCA for limited XP, providing predictable single-session clearance, superior cosmetic outcomes, fewer pigmentary changes and higher patient satisfaction. Excision can be considered the preferred first-line therapy for localized XP.
- Open Access
- 27 June 2025
- Published by Wolters Kluwer Health in Indian Dermatology Online Journal
- Vol. 16 (4) , 607-611
Raccoon Eyes in Dermatology Revisited
- 27 June 2025
- Published by Wolters Kluwer Health in Indian Dermatology Online Journal
- Vol. 16 (4) , 607-611
Open AccessRaccoon Eyes in Dermatology Revisited
- 24 June 2025
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 119 (11) , 1250-1258
Early detection of subclinical neuropathy and its evolution in newly diagnosed patients of leprosy started on multidrug therapy
Background: Early detection of nerve impairment and its progression is critical in all leprosy cases, regardless of spectrum and treatment. This study aims to identify subclinical neuropathy at presentation in newly diagnosed leprosy patients and to monitor its progression after initiating multidrug therapy (MDT) using a combination of clinical nerve palpation, small fibre neuropathy tests (e.g. vibration, temperature, touch, pain, sweat), monofilament testing (MFT), voluntary muscle testing (VMT) and nerve conduction studies (NCSs). Methods: We studied 38 nerves among 19 patients and followed them for 12 months to assess neuropathy progression. Nerve palpation was evaluated clinically at baseline, while MFT was performed on the ulnar, median and posterior tibial nerves at baseline and 1 y. VMT and NCSs were conducted at both baseline and 12 months. Small fibre neuropathy was assessed using temperature (test tube), vibration (vibration perception threshold), sweating (starch iodide test) and pain responses at baseline. Results: Among the study cohort, 52.6% had borderline tuberculoid leprosy, followed by lepromatous leprosy (31.5%). Seven patients (36.8%) presented with a reaction at baseline. Major nerve trunks that were thickened included the ulnar nerve (52.6%) and common peroneal nerve (31.6%). Five patients had normal NCSs at baseline and 14 (73.4%) had abnormalities at baseline through NCSs and MFT. Thickened nerves had decreased nerve conduction and amplitude at baseline and more in the lepromatous spectrum. When they were followed up, two patients improved, five had no change and seven worsened from baseline in the NCSs. One patient had an abnormal NCS when followed up from the normal baseline NCS. The pattern of neuropathy was predominantly axonal and two of them were mixed (both axonal and demyelinating). MFT, compared with NCSs, was found to help detect both small and large fibre involvement. Conclusions: A combination of clinical tests and periodic NCSs is essential for detecting the progression of leprosy neuropathy. Neuropathy continued to progress despite 1 y of MDT, particularly in patients with early involvement at baseline.
- 24 June 2025
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 119 (11) , 1250-1258
Early detection of subclinical neuropathy and its evolution in newly diagnosed patients of leprosy started on multidrug therapy
Background: Early detection of nerve impairment and its progression is critical in all leprosy cases, regardless of spectrum and treatment. This study aims to identify subclinical neuropathy at presentation in newly diagnosed leprosy patients and to monitor its progression after initiating multidrug therapy (MDT) using a combination of clinical nerve palpation, small fibre neuropathy tests (e.g. vibration, temperature, touch, pain, sweat), monofilament testing (MFT), voluntary muscle testing (VMT) and nerve conduction studies (NCSs). Methods: We studied 38 nerves among 19 patients and followed them for 12 months to assess neuropathy progression. Nerve palpation was evaluated clinically at baseline, while MFT was performed on the ulnar, median and posterior tibial nerves at baseline and 1 y. VMT and NCSs were conducted at both baseline and 12 months. Small fibre neuropathy was assessed using temperature (test tube), vibration (vibration perception threshold), sweating (starch iodide test) and pain responses at baseline. Results: Among the study cohort, 52.6% had borderline tuberculoid leprosy, followed by lepromatous leprosy (31.5%). Seven patients (36.8%) presented with a reaction at baseline. Major nerve trunks that were thickened included the ulnar nerve (52.6%) and common peroneal nerve (31.6%). Five patients had normal NCSs at baseline and 14 (73.4%) had abnormalities at baseline through NCSs and MFT. Thickened nerves had decreased nerve conduction and amplitude at baseline and more in the lepromatous spectrum. When they were followed up, two patients improved, five had no change and seven worsened from baseline in the NCSs. One patient had an abnormal NCS when followed up from the normal baseline NCS. The pattern of neuropathy was predominantly axonal and two of them were mixed (both axonal and demyelinating). MFT, compared with NCSs, was found to help detect both small and large fibre involvement. Conclusions: A combination of clinical tests and periodic NCSs is essential for detecting the progression of leprosy neuropathy. Neuropathy continued to progress despite 1 y of MDT, particularly in patients with early involvement at baseline.
- 15 November 2024
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (4) , 888-890
A solitary cockade purpuric lesion in a pregnant woman
A pregnant woman presented to our dermatology department (Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India) with a solitary cockade purpuric lesion over the abdomen, present for 5 days.
- 15 November 2024
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (4) , 888-890
A solitary cockade purpuric lesion in a pregnant woman
A pregnant woman presented to our dermatology department (Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India) with a solitary cockade purpuric lesion over the abdomen, present for 5 days.
- 1 January 2024
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 160 (1) , 102
Acrodermatitis Enteropathica
A woman in her 20s presented for evaluation of painful, red skin lesions that had first presented 6 months prior and involved the face, groin, and extremities. It was insidious in onset, initially appearing over the groin and gradually progressing to involve other sites. A previous episode of similar lesions occurred at 1 year of age during weaning from breast milk, which improved with zinc supplementation. She denied food faddism, gastrointestinal complaints, or prior drug intake. A family history of similar skin lesions was absent. On examination, there were sharply demarcated erythematous erosive plaques with crusting seen over the periorificial areas of the face and groin along with involvement of the dorsum of the hands and feet (Figure). There was diffuse nonscarring alopecia involving the scalp and eyebrows. Serum zinc levels were found to be low (23 µg/dL; normal range: 50-150 µg/dL; to convert to µmol/L, multiply by 0.153) along with a low serum alkaline phosphatase level (31 U/L; normal range: 44-147 U/L; to convert to µkat/L, multiply by 0.0167). Histopathology revealed psoriasiform epidermal hyperplasia with confluent parakeratosis and epidermal pallor consistent with acrodermatitis enteropathica (AE). Oral zinc supplementation was initiated at a dose of 3 mg/kg, with rapid improvement.
- 1 January 2024
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 160 (1) , 102
Acrodermatitis Enteropathica
A woman in her 20s presented for evaluation of painful, red skin lesions that had first presented 6 months prior and involved the face, groin, and extremities. It was insidious in onset, initially appearing over the groin and gradually progressing to involve other sites. A previous episode of similar lesions occurred at 1 year of age during weaning from breast milk, which improved with zinc supplementation. She denied food faddism, gastrointestinal complaints, or prior drug intake. A family history of similar skin lesions was absent. On examination, there were sharply demarcated erythematous erosive plaques with crusting seen over the periorificial areas of the face and groin along with involvement of the dorsum of the hands and feet (Figure). There was diffuse nonscarring alopecia involving the scalp and eyebrows. Serum zinc levels were found to be low (23 µg/dL; normal range: 50-150 µg/dL; to convert to µmol/L, multiply by 0.153) along with a low serum alkaline phosphatase level (31 U/L; normal range: 44-147 U/L; to convert to µkat/L, multiply by 0.0167). Histopathology revealed psoriasiform epidermal hyperplasia with confluent parakeratosis and epidermal pallor consistent with acrodermatitis enteropathica (AE). Oral zinc supplementation was initiated at a dose of 3 mg/kg, with rapid improvement.
- Open Access
- 4 April 2023
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 34 (1) , 2182618
Efficacy of autologous platelet-rich plasma therapy versus topical Minoxidil in men with moderate androgenetic alopecia: a randomized open-label trial
Platelet-rich plasma (PRP) is an adjunctive treatment in androgenetic alopecia (AGA). Its role as a monotherapy, when compared to FDA-approved therapies in moderate grades of androgenetic alopecia ...
- 4 April 2023
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 34 (1) , 2182618
Open AccessEfficacy of autologous platelet-rich plasma therapy versus topical Minoxidil in men with moderate androgenetic alopecia: a randomized open-label trial
Platelet-rich plasma (PRP) is an adjunctive treatment in androgenetic alopecia (AGA). Its role as a monotherapy, when compared to FDA-approved therapies in moderate grades of androgenetic alopecia ...
- 2 February 2023
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 49 (3) , 231-236
Surgical Matricectomy Versus Phenolization in the Treatment of Ingrown Toenails: A Randomized Controlled Trial
BACKGROUND: Treatment of ingrown toenail includes various nonsurgical and surgical treatments. However, there is no consensus on the ideal first-choice treatment. OBJECTIVE: To compare phenolization versus surgical matricectomy (SM) after lateral nail plate avulsion in terms of efficacy, recurrence rates, postoperative outcomes, and cosmesis. METHODS: The authors enrolled 45 consenting patients and randomized them into 2 groups (Group 1 = phenolization and Group 2 = SM) using stratified block randomization and followed them up at 1 week, 1 month, and 6 months. RESULTS: The median percentage improvement in pain visual analog scale (VAS) score was comparable between the 2 groups (p = 0.793). The mean photo VAS showed significant improvement in Group 1 at 1 week (p = 0.00) and 1 month (p = 0.02) but not at 6 months (p = 0.44). The median number of days for pain relief (p = 0.169), for healing (p = 0.192), and for resuming work (p = 0.136) were not significantly different between the 2 groups. The time required to regain normal morphology was significantly longer in Group 2 (p = 0.006). None of the patients in either group presented with recurrence at 6 months and 1 year. The authors observed failure of treatment in 1 patient in Group 2. CONCLUSION: Both procedures were equally efficacious, had minimal complications, and showed no recurrence at 6 months and 1 year.
- 2 February 2023
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 49 (3) , 231-236
Surgical Matricectomy Versus Phenolization in the Treatment of Ingrown Toenails: A Randomized Controlled Trial
BACKGROUND: Treatment of ingrown toenail includes various nonsurgical and surgical treatments. However, there is no consensus on the ideal first-choice treatment. OBJECTIVE: To compare phenolization versus surgical matricectomy (SM) after lateral nail plate avulsion in terms of efficacy, recurrence rates, postoperative outcomes, and cosmesis. METHODS: The authors enrolled 45 consenting patients and randomized them into 2 groups (Group 1 = phenolization and Group 2 = SM) using stratified block randomization and followed them up at 1 week, 1 month, and 6 months. RESULTS: The median percentage improvement in pain visual analog scale (VAS) score was comparable between the 2 groups (p = 0.793). The mean photo VAS showed significant improvement in Group 1 at 1 week (p = 0.00) and 1 month (p = 0.02) but not at 6 months (p = 0.44). The median number of days for pain relief (p = 0.169), for healing (p = 0.192), and for resuming work (p = 0.136) were not significantly different between the 2 groups. The time required to regain normal morphology was significantly longer in Group 2 (p = 0.006). None of the patients in either group presented with recurrence at 6 months and 1 year. The authors observed failure of treatment in 1 patient in Group 2. CONCLUSION: Both procedures were equally efficacious, had minimal complications, and showed no recurrence at 6 months and 1 year.
- Open Access
- 31 January 2023
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 13 (1) , e2023044
Pigmented Macular Variant of Chronic Cutaneous Lupus Erythematosus: Clinico-dermoscopic Features of Three Patients With Skin of Color
Citation: Behera B, Kumari R, Gochhait D, Ayyanar P. Pigmented macular variant of chronic cutaneous lupus erythematosus: Clinico-dermoscopic features of three patients with skin of color. Dermatol Pract Concept. 2023;13(1):e2023044. DOI: https://doi.org/10.5826/dpc.1301a44 Accepted: September 16, 2022; Published: January 2023 Copyright: ©2023 Behera et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Rashmi Kumari, M.D., Associate Professor, Dept. of Dermatology, Venereology and Leprology, JIPMER, Puducherry, Pin-605006. Phone no- 09489692199, Email: rashmi.sreerag@gmail.com This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
- 31 January 2023
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 13 (1) , e2023044
Open AccessPigmented Macular Variant of Chronic Cutaneous Lupus Erythematosus: Clinico-dermoscopic Features of Three Patients With Skin of Color
Citation: Behera B, Kumari R, Gochhait D, Ayyanar P. Pigmented macular variant of chronic cutaneous lupus erythematosus: Clinico-dermoscopic features of three patients with skin of color. Dermatol Pract Concept. 2023;13(1):e2023044. DOI: https://doi.org/10.5826/dpc.1301a44 Accepted: September 16, 2022; Published: January 2023 Copyright: ©2023 Behera et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Rashmi Kumari, M.D., Associate Professor, Dept. of Dermatology, Venereology and Leprology, JIPMER, Puducherry, Pin-605006. Phone no- 09489692199, Email: rashmi.sreerag@gmail.com This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
- Open Access
- 31 January 2023
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 13 (1) , e2023045
Preliminary Dermoscopic Features of Discoid Lupus Cheilitis in Eight Patients of Skin Of Color
Citation: Behera B, Kumari R, Srinivas BH, Ch Toi P, Gochhait D, Ayyanar P. Preliminary Dermoscopic Features Of Discoid Lupus Cheilitis In Eight Patients Of Skin Of Color. Dermatol Pract Concept. 2023;13(1):e2023045. DOI: https://doi.org/10.5826/dpc.1301a45 Accepted: September 14, 2022; Published: January 2023 Copyright: ©2023 Behera et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Rashmi Kumari, M.D., Associate Professor, Dept. of Dermatology, Venereology and Leprology, JIPMER, Puducherry, Pin-605006. Phone no- 09489692199, Email: rashmi.sreerag@gmail.com Keywords : cheilitis, dermoscopy, lupus, pigmentation This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
- 31 January 2023
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 13 (1) , e2023045
Open AccessPreliminary Dermoscopic Features of Discoid Lupus Cheilitis in Eight Patients of Skin Of Color
Citation: Behera B, Kumari R, Srinivas BH, Ch Toi P, Gochhait D, Ayyanar P. Preliminary Dermoscopic Features Of Discoid Lupus Cheilitis In Eight Patients Of Skin Of Color. Dermatol Pract Concept. 2023;13(1):e2023045. DOI: https://doi.org/10.5826/dpc.1301a45 Accepted: September 14, 2022; Published: January 2023 Copyright: ©2023 Behera et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Rashmi Kumari, M.D., Associate Professor, Dept. of Dermatology, Venereology and Leprology, JIPMER, Puducherry, Pin-605006. Phone no- 09489692199, Email: rashmi.sreerag@gmail.com Keywords : cheilitis, dermoscopy, lupus, pigmentation This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.